|
Overview | Product information | Accredo services | Contact team
Adagen is an enzyme replacement therapy indicated for adenosine deaminase (ADA) deficiency in patients with severe combined immunodeficiency disease (SCID) who are not suitable candidates for—or who have failed—bone marrow transplantation.
For more information, please download the full prescribing information.
Adagen is a registered trademark of Sigma-Tau Pharmaceuticals, Inc.
|